The support [the Los Angeles County Proton Therapy Center has] received demonstrates that the government wants this project to succeed, and that makes it one of the best, most secure offerings out there for EB-5 investors.
Grand Rapids, MI (PRWEB) May 14, 2013
EB-5 Investment Insights, a third party research group specializing in the analysis of investment opportunities within the United States’ EB-5 pilot program, endorsed the Los Angeles County Proton Therapy Center (“LACPTC”) project this past week. This highly-anticipated, state-of-the-art proton therapy center is currently being offered as an EB-5 immigrant investment opportunity by the Pacific Proton Therapy Regional Center (“PPTRC”), a U.S. Federal Government-approved EB-5 Regional Center located in Southern California. Construction of the therapy center will soon be underway at an approved site in Montebello, California, and is funded in part by EB-5 capital. Through the United States’ EB-5 pilot program, foreign investors are given a path to residency in return for financing job-creating domestic projects with half-million dollars or more.
EB-5 Investment Insights promotes the Los Angeles County Proton Therapy Center, which is run by an experienced and accomplished management team, as a strong and secure project. Letters of support for proton technology and the LACPTC from local and Federal government leaders, including California House of Representatives members such as Congresswoman Representative Grace Napolitano, reinforce the project's security by making known the public officials' desire to see it succeed. The letters also acknowledge the documented clinical advantages of proton therapy, such as superior targeting of tumors and significant reduction of side effects, and recognize that the LACPTC directly addresses exponential growth in proton therapy demand while also creating jobs here in the United States.
“The benefits this therapy center will bring to the community in terms of job creation and cutting-edge health care are enormous,” said LACPTC Chairman and CEO, Dr. John P. Thropay. “Unlike many EB5 projects such as casinos or shopping malls, which are just about developers making money, The Proton Therapy Center is highly desirable by the community and the government. The support we have received demonstrates that the government wants this project to succeed, and that makes it one of the best, most secure offerings out there for EB-5 investors.”
However, the cutting-edge cancer treatment and economic growth to be provided by the facility are not the only things that make LACPTC an outstanding project, according to the project management team. Proton treatment is eligible for government reimbursement via Medicare and Medicaid, meaning the project has verified cash flow. In addition, the Los Angeles County Proton Therapy Center project makes use of the safest escrow in EB-5, provides immigrant investors with priority status with United States Citizenship and Immigration Services (“USCIS”), and guarantees I-526 approval or the investor is given a full refund.
“We are proud to offer the Los Angeles Country Proton Therapy Center project, and believe it is the strongest available to immigrant investors,” continued Dr. Thropay. “Our team welcomes the partnership of immigrant investors as we work to bring the best possible outcome to cancer patients and investors alike.”
EB-5 Investment Insights is a privately-owned third party research group that specializes in analyzing areas of investment within the United States EB-5 program.